Skip to content
HowShorted

ARS Pharmaceuticals, Inc. short interest in 2021

In 2021, ARS Pharmaceuticals, Inc.'s disclosed short interest ran from 9.22% of shares outstanding on 14 May 2021 to 4.49% on 31 Dec 2021, a change of -4.73 percentage points. The year's high was 11.61% on 15 Nov 2021 and its low 4.49% on 31 Dec 2021, averaging 9.11% across 16 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 37.21 days on 13 Aug 2021. Full history: ARS Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ARS Pharmaceuticals, Inc. in 2021

2021 in figures

Start of year
9.22% (14 May 2021)
End of year
4.49% (31 Dec 2021)
Change
-4.73 pp
High
11.61% (15 Nov 2021)
Low
4.49% (31 Dec 2021)
Average
9.11%
Highest days to cover
37.21 (13 Aug 2021)
SEC filings marked
8

Every report in 2021

ARS Pharmaceuticals, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
14 May 20219.22%27.3610-K filed, results (8-K), 10-Q filed, results (8-K)
28 May 20219.14%28.55
15 Jun 20219.50%29.11
30 Jun 20219.15%21.30
15 Jul 20218.72%26.77
30 Jul 20219.21%25.24
13 Aug 20219.25%37.2110-Q filed, results (8-K)
31 Aug 20219.34%12.43
15 Sep 202110.45%5.51
30 Sep 202111.49%5.38
15 Oct 202111.29%7.78
29 Oct 202111.07%9.41
15 Nov 202111.61%10.7710-Q filed, results (8-K)
30 Nov 20216.29%6.27
15 Dec 20215.48%3.43
31 Dec 20214.49%3.78

See also: ARS Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.